rs573729300
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP6_ModerateBS1
The NM_006420.3(ARFGEF2):c.-24_-1delGTCAGCCCCCGCCGGGCCGGGGCC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000413 in 1,503,662 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_006420.3 5_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARFGEF2 | NM_006420.3 | c.-24_-1delGTCAGCCCCCGCCGGGCCGGGGCC | 5_prime_UTR_variant | Exon 1 of 39 | ENST00000371917.5 | NP_006411.2 | ||
ARFGEF2 | NM_001410846.1 | c.-24_-1delGTCAGCCCCCGCCGGGCCGGGGCC | 5_prime_UTR_variant | Exon 1 of 39 | NP_001397775.1 | |||
ARFGEF2 | XM_047439832.1 | c.-433_-410delGTCAGCCCCCGCCGGGCCGGGGCC | 5_prime_UTR_variant | Exon 1 of 37 | XP_047295788.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00144 AC: 219AN: 151900Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000455 AC: 54AN: 118654Hom.: 0 AF XY: 0.000420 AC XY: 27AN XY: 64274
GnomAD4 exome AF: 0.000297 AC: 402AN: 1351652Hom.: 1 AF XY: 0.000321 AC XY: 214AN XY: 666382
GnomAD4 genome AF: 0.00144 AC: 219AN: 152010Hom.: 0 Cov.: 32 AF XY: 0.00139 AC XY: 103AN XY: 74328
ClinVar
Submissions by phenotype
ARFGEF2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not specified Benign:1
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at